QTTB Q32 Bio Inc.

NASDAQ
$8.48

Q32 Bio Inc. (QTTB) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus QTTB's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
6 transactions
Purchases
$0
0 shares
Sales
$320.4K
22,054 shares
Net activity
-$320.4K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $320.4K 6 transactions · 22,054 shares

Largest single sale: $163.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: May 28, 2026 .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Morrison Jodie Pope CEO Sell 3,221 $8.32 $26.8K 340,038 −0.9% of holding
Kalowski Lee CFO and President Sell 1,301 $8.32 $10.8K 137,170 −0.9% of holding
Violette Shelia M. Chief Scientific Officer Sell 917 $8.32 $7.6K 126,854 −0.7% of holding
Morrison Jodie Pope CEO Sell 9,845 $16.56 $163.0K 343,259 −2.8% of holding
Kalowski Lee CFO and President Sell 3,972 $16.56 $65.8K 138,471 −2.8% of holding
Violette Shelia M. Chief Scientific Officer Sell 2,798 $16.56 $46.3K 127,771 −2.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.